Beauty Beyond Borders: A Comprehensive Guide to Cosmetic Regulations in Saudi Arabia

Beauty Beyond Borders: A Comprehensive Guide to Cosmetic Regulations in Saudi Arabia

In recent years, the beauty and cosmetics industry has witnessed exponential growth worldwide, breaking down geographical barriers and creating a global marketplace.

One country that has embraced this transformative trend is Saudi Arabia, where the beauty industry has flourished, reflecting the changing cultural landscape. However, with growth comes the need for regulations to ensure consumer safety and product quality.

Legal Framework for Saudi Arabia Cosmetic Regulations

Saudi Arabia has established a robust legal framework to govern the cosmetics industry, ensuring that products meet stringent safety, efficacy, and quality standards. The Saudi Food and Drug Authority (SFDA) plays a pivotal role in regulating cosmetics and ensuring manufacturers follow the Cosmetic Regulations in Saudi Arabia.

The SFDA operates in accordance with international best practices, harmonizing its regulations with global standards to facilitate the import and sale of cosmetics in Saudi Arabia.

The Law of Cosmetic Products promulgated by Royal Decree number M/49 on 18/6/1436 AH is the Cosmetic Regulation followed in Saudi Arabia.

Registration Process for Cosmetic Regulations in Saudi Arabia

One of the primary requirements for cosmetic products entering the Saudi market is registration with the SFDA. Manufacturers and distributors must submit detailed documentation about their products, including information on ingredients, formulations, and safety assessments.

This rigorous registration process guarantees that cosmetics comply with Saudi regulations and do not pose any health risks to consumers.

Notifying is listing cosmetic products in the SFDA records via the Cosmetic Notification system (eCosma) and does not mean SFDA has evaluated the product safety.

Notifying aims to create a comprehensive database of cosmetic products manufactured locally or imported by recording them in SFDA records, and the notifier (responsible person) shall comply with the validity of the information entered and the safety of the products.

Product Testing and Safety

Cosmetic products must undergo rigorous safety assessments to meet the SFDA’s standards. This includes testing for microbiological contamination, stability, and compliance with permissible limits of certain ingredients.

Manufacturers are responsible for providing evidence of product safety during the registration or notification process.

Halal Certification

Given the cultural and religious context of Saudi Arabia, the concept of Halal (permissible in Islam) is of utmost importance. Like other consumer goods, cosmetic products may undergo Halal certification to ensure they adhere to Islamic principles.

While Halal certification is not mandatory, many manufacturers seek it as a mark of authenticity and to appeal to the sensibilities of the Saudi consumer base.

Ingredient Restrictions

Saudi Arabia imposes strict regulations on the ingredients used in cosmetics. Certain substances are prohibited or restricted due to their potential harm to consumers. The SFDA maintains a list of restricted ingredients, and compliance is mandatory for all cosmetic products sold in the country.

This includes a comprehensive ban on ingredients that are considered hazardous or pose a risk to human health. The notifier (responsible person) must ensure the integrity of the entered data and the product’s safety.

Note that the Authority published a list of the banned products and restricted use in the cosmetic products in addition to a list of preservatives and colouring items allowed in the Cosmetic Products Website in accordance to article four of the Implementing Regulation of the Cosmetic Products Law.

Labelling Requirements for Cosmetic Regulations in Saudi Arabia

Precise and accurate labelling is crucial for consumer safety and informed choices. The SFDA mandates that all cosmetic products bear labels in Arabic, providing essential information such as product name, ingredients, instructions for use, and contact details of the manufacturer or distributor. Compliance with these labelling requirements is essential for market access and consumer trust.

  • When submitting cosmetic product notifications, a clear image (one or more) of the product from all sides that shows its information and substitutions in a visible and readable way is required. The image shall include the internal and external product label and its internal brochure, if any. The images can be presented in one of the following forms: PNG, JPG, TIFF, or PDF. 
  • The cosmetic product label shall confirm with the Cosmetic Products Legislation and the Standard of Safety Requirements for Cosmetic Products and personal care No. GSO1943/20016.
  • The product label must contain its barcode and shall be entered into the cosmetic notification system, taking into account the product’s size and colour.

Post-Market Surveillance

To ensure ongoing consumer safety, the SFDA conducts post-market surveillance to monitor the safety and quality of cosmetic products already in circulation.

This involves regular inspections, product sampling, and analysis to identify potential risks or violations. Manufacturers and distributors must cooperate fully with the SFDA during these surveillance activities to maintain compliance.


Saudi Arabia’s cosmetics industry thrives, driven by a dynamic consumer base seeking high-quality, safe, and culturally appropriate products. The regulatory framework established by the SFDA plays a pivotal role in maintaining the integrity of the market and ensuring that cosmetics meet the highest standards.

As the industry continues to evolve, staying abreast of the regulatory landscape is imperative for businesses seeking success in Saudi Arabia’s beauty sector.

Beauty truly knows no borders, and by understanding and adhering to the regulations, companies can contribute to the flourishing beauty industry in the Kingdom while prioritizing consumer well-being.

Understanding Borderline Cosmetics in the EU

Understanding Borderline Cosmetics in the EU

Understanding the distinctions between product classes within the European cosmetics landscape can be complex and ambiguous, often requiring input from authoritative bodies.

Certain products may share similarities but fall under different regulatory frameworks. When products straddle these frameworks, they’re termed “borderline” by the European Commission (EC). Clear comprehension of a product category is vital to determine the regulatory requisites for the specific market.

Difficulties in evaluating and classifying products can arise even within the EU’s legal framework. For instance, within the EU Cosmetic Regulation 1223/2009, a mouthwash claiming “antibacterial” or “antiseptic” properties could fit into various categories: cosmetics, biocidal products, or medicinal products.

Additionally, if the product involves a device, like implants, it might be categorized as a medical device. The EC makes decisions regarding the classification of these “borderline products” on a case-by-case basis.

Definition of a Cosmetic product

A cosmetic product, as defined by the EU Cosmetic Regulation, shall mean any substance or mixture intended to be placed in contact with the various external parts of the human body or with the teeth and mucous membranes of the oral cavity for the purposes of cleaning them, perfuming them, changing their appearance, correcting body odours, and protecting them or keeping them in good condition.

The purpose/function, formulation, and application site must be clearly defined to classify a cosmetic product under the EU Cosmetic Regulation.

EU Cosmetic Regulation Functions

Cosmetic products serve primary purposes such as altering appearance (as in makeup), cleansing, enhancing beauty, imparting fragrance, safeguarding, or rectifying odors.

Additionally, these products can possess secondary functions, like biocidal or antimicrobial effects in oral hygiene items or deodorants primarily intended for cosmetic use.

When assessing a cosmetic’s function, crucial considerations encompass the manufacturer’s intent, presentation, labelling, advertising, claims, mode of action, composition, and how consumers perceive it. With a clearly defined primary function, a cosmetic product can avoid falling into a different product category.


The composition of a cosmetic product strongly determines its function. Claims often rely on specific ingredients used in the product’s formulation, such as those linked to therapeutic use (like fluoride in toothpaste).

To meet standards, a cosmetic’s formulation should avoid prohibited ingredients listed in Annex II of the EU Cosmetic Regulation, adhere to restrictions in Annex III, and comply with guidelines for colorants (Annex IV), preservatives (Annex V), and ultraviolet (UV) filters (Annex VI).

EU Cosmetic Regulation Application Site

Cosmetic products are designed to be applied to the outer surfaces of the human body, including the epidermis, hair, nails, lips, external genital organs, as well as the teeth and mucous membranes within the oral cavity.

Definition of biocidal product

A biocidal product contains an active substance to eradicate, deter, neutralise, or control harmful or unwanted organisms. The primary function indicated by its claims plays a pivotal role in distinguishing between a cosmetic and a biocidal product.

For instance, bath soaps boasting antibacterial or antiseptic properties fall under biocidal products, as do sunscreens with their UV protection abilities.

Definition of the medicinal product

As per Directive 2001/83/EC, a medicinal product is any substance or blend possessing therapeutic or preventive properties in humans. This encompasses substances administered to restore, correct, or alter physiological functions through pharmacological, immunological, or metabolic actions, or for medical diagnosis.

For instance, shampoo is labeled a cosmetic product as its primary purpose is hair cleansing. Conversely, an anti-dandruff treatment is classified as a drug due to its intended use for dandruff treatment via pharmacological action.

Therefore, an anti-dandruff shampoo holds both cosmetic and drug classifications.

Definition of a Medical Device

According to European Union Regulation (EU) 2017/745, a medical device refers to any instrument, apparatus, equipment, software, implant, reagent, material, or another article, used alone or in combination.

In short, a medical device is intended for use in human beings for a disease, injury or disability, an anatomical structure or function, a physiological or pathological process, as well as other special medical cases.

Furthermore, this regulation encompasses specific products intended for aesthetic purposes, such as colored contact lenses, devices emitting high-intensity electromagnetic radiation like lasers, and intense pulsed light equipment utilized for skin treatments such as resurfacing, tattoo removal, hair removal, or other skin-related procedures.

Numerous medical devices are employed on superficial areas of the human body. The key distinction of a medical device lies in its claim for medical use or association with aesthetic categories, setting it apart from cosmetic products.

For instance, a foot cream designed for moisturizing dry skin is considered a cosmetic product. However, if it includes a claim to heal damaged skin displaying cracks or fissures, it would be reclassified as a medical device.


Wrong product classification can negatively impact a business. It can have serious safety ramifications for the end user if the intended product use or function needs to be clarified or understood.

Other direct consequences can include potential product recalls, redesign of product labels, re-application or re‑notification to the appropriate competent authorities, reformulation of the product, and application for variation in some product class within the same regulatory framework. There is also the burden of associated costs, loss of brand reputation, loss of time, etc.

It is imperative that manufacturers, suppliers, and distributors correctly classify their products from the onset; this will subject the product to the appropriate regulatory framework and meet relevant compliance requirements.

In the case of uncertainty, the competent national authorities in the EU and UK Member States will decide on a case-by-case basis. Do you have questions about this topic, your obligations under the relevant regulatory framework, or a related topic?

Please get in touch with us at [email protected].

How can OMC help you?

  • Act as your EU Authorised representative.
  • Act as your EU responsible person.
  • MDR and Cosmetics regulation compliance
  • Provide appropriate regulatory strategy and consultations
  • Product classification
Cosmetics Product Recall under FDA

Cosmetics Product Recall under FDA

Title 21 of the Code of Federal Regulations (CFR), section 7.3(g), describes a recall as a firm’s removal or correction of a marketed product that FDA judges to be in violation of the laws we administer and against which the FDA would start legal action, such as seizure.

FDA strongly advises businesses to familiarise themselves with all of the regulations, including the elements of a recall strategy, in 21 CFR Part 7.

What is the FDA’s responsibility in a recall of Cosmetics Product?

The FD&C Act does not give FDA the authority to mandate the recall of a cosmetic product, but it does give FDA the authority to request a company to do so. They do, however, actively participate in recalls.

  • The FDA keep track of recall developments. They may perform their own audit inspections at wholesale or retail customers in addition to examining company status reports to ensure the recall’s efficacy.
  • The FDA determines the level of the health risk posed by a product under recall and assigns a classification to represent that risk:
    • Class I: There is a foreseeable risk that using or being exposed to a prohibited cosmetics product may have grave implications for one’s health or result in death.
    • Class II – Where there is a remote chance that using or being exposed to a contraband product will result in transitory or medically treatable adverse health effects.
    • Class III: No adverse consequences to health is posed by using or being exposed to a contraband product.
  • The FDA or the company may issue a public notification if it determines that it is necessary. The FDA will publish a press statement if the company declines or unreasonably postpones doing so. The FDA Enforcement Report, a weekly publication that includes details on all recalls for which classification has been assigned, is another way that FDA disseminates broad information on recalls.
  • If FDA requests a recall, they create a suggested plan for each recall that specifies how the Agency wants it to be executed and whether a press statement is required. The FDA will analyse and offer comments on the firm’s recall strategy if one is developed.
  • The FDA guarantees that the product is either destroyed or properly refurbished.

What is a cosmetics product company’s responsibility in a recall?

The following is what the company is required to do in accordance with 21 CFR Part 7:

  • Customers should be notified by the company. According to 21 CFR 7.49, the notification’s format, content, and scope should be appropriate for the risk the product poses and the recall plan that was created for it.
  • When a recall is announced, the company must inform the relevant FDA district office.
  • Periodic recall status updates should be sent by the company to the relevant FDA district office so that the FDA can monitor the recall’s development.
  • If the company or FDA decides that a public warning is essential, they should submit a statement to that effect along with a distribution strategy for FDA’s assessment and feedback.
  • The business must carry out effectiveness checks in accordance with 21 CFR 7.42(b) (3).
  • Whether the recalled product is destroyed or brought into compliance, the corporation oversees how it is handled.

How can the recall process be easier and more effective?

The simplest method to reduce the workload associated with product recalls is to thoroughly avoid product adulteration and misbranding in the first place. However, by being ready in advance, businesses can reduce the damage in the event that a recall is required.

  • Keep a backup plan in place in case a recall needs to be started in accordance with the recall rules.
  • Give numbers to production lots or batches. Law does not mandate lot numbers for cosmetics product. But it enables you to decide if some or all cosmetics products lots need to be recalled. Since it will probably be impossible to pinpoint the exact production runs implicated if the items don’t have lot numbers, it might be required to recall every cosmetics product currently on the market.
  • Keep proper distribution data to make it easier to find recalled cosmetics products. Keep them around for longer than the product’s expected shelf life and utilise.

How to prevent similar problems?

The corporation should take the kind of remedial efforts that stop a similar issue from happening in the future, in addition to the corrective actions of withdrawing a violative product from the market and either destroying it or bringing it into compliance.

  • Identify the cause of the violation,
  • Decide what adjustments need to be made to prevent the issue from occurring again
  • Execute such modifications

When conducting an inspection in connection with a recall, an FDA inspector may check for these factors.


What is a Recall Strategy?

A recall strategy is a predetermined course of action to be followed in carrying out a given recall, considering the scope of the recall, the requirement for public warnings, and the extent of effectiveness checks.
Recalling firm refers to the company that requests a recall or, in the case of a recall requested by the FDA, the company that oversees the production and marketing of the recalled product.

What is the procedure for a Recall?

1.       Initiation of a Recall. Includes voluntary, and non-voluntary recalls.
2.      Identification of the Action as a Recall; Classification; and Strategy. By determining that the action satisfies the requirements of a recall under 21 CFR 7.3(g)1 or the applicable definitions for recalls carried out under various regulatory or statutory authorities, FDA formalises the recall action. FDA evaluates the data, including the firm’s recall plan, determines the level of health risk the recalled product presents, and then classifies the recall in line with 21 CFR 7.41.
3.      Notification and announcement to the public. FDA evaluates a company’s recall strategy and makes improvements, such as the publication of a public statement. FDA notifies the company of the recall’s categorization. The agency has the right to publish a recall statement on its own. Other federal and state government agencies, as well as international governments, receive recall information from FDA.
4.      Recall monitoring and auditing. In order to make sure that the recall action has been successful, FDA designs and implements a recall audit plan.
5.      Termination of a Recall. The FDA decides when to call off a recall.

What is Recall Enterprise System (RES)?

The FDA’s recall staff submits, updates, categorises, and ends recalls using the Recall Enterprise System (RES), an electronic data system. Safety Alerts for medical devices are also recorded using it. Stock recoveries and market withdrawals are typically not recorded in RES. However, divisions may be instructed by the Center Recall Unit (CRU) or OSPOP/DE/ROB to enter a specific market withdrawal into RES and to monitor and audit the action in the same way as a recall, if this is done in accordance with agency policy.

What is a Recall Alert?

Once the division recall coordinator is aware that a recall has been started and has the appropriate information, the division will send a recall alert via the RES within one working day. Additionally, alerts may be sent even before a recall has begun. A firm’s correction or removal, the cause of the recall, and the predicted categorization are all disclosed in the recall alert in order to inform the appropriate Center Recall Unit (CRU) and OSPOP/DE/ROB. Copy the division recall personnel where the production site or responsible firm is located for recalls where the responsible firm or manufacturing site is located outside the monitoring division.

FDA’s Adverse Event Reporting for Cosmetics

FDA’s Adverse Event Reporting for Cosmetics

Cosmetic ingredients and products are not required to have FDA clearance before being sold in the U.S. The only exception is colour additives, which need to be authorised for their intended purpose (apart from the colouring agents used in coal-tar hair dyes).

Companies and individuals that sell cosmetics have a legal obligation to guarantee the security of their products. The FDA requires trustworthy evidence that shows that a cosmetic product is harmful when used as directed by its label or in the usual or anticipated manner before they take safety measures against it.

Adverse events in Cosmetics

The FDA keeps an eye on cosmetics sold on the market to make sure people may use them safely. When a consumer, manufacturer, or medical practitioner submits an adverse event report (AER), FDA may learn of a safety concern. Any issue that occurs after using a cosmetic product might be considered an adverse event.

The main categories of hair care (including shampoos, conditioners, hair smoothing treatments, and hair dyes) and skin care products are where cosmetic product adverse events are most commonly recorded.

In addition, rinse-off products are reported more frequently than leave-on ones. Certain products have been the focus of numerous adverse reports in recent years.

The data about the adverse report is sent to CAERS by the FDA’s MedWatch Safety Information and Adverse Event Reporting Program, which serves as the entry point for reports about all products subject to FDA regulation.

These reports are not yet confirmed, and this data is unprocessed. However, they are crucial as it is one of the FDA’s few tools to track any cosmetics-related safety issues.

Care must be used while interpreting the reports. The database can provide the public with some broad information about the types of difficulties if any, that other users have reported encountering if anyone is considering utilising a certain product.

How do FDA take action on these adverse safety reports?

FDA constantly monitors adverse event reports and reviews the relevant scientific literature. The following step is to coordinate an examination of the production facilities with the FDA’s Office of Compliance.

The FDA may send warning letters informing businesses that they have noticed legal infractions based on what they discover during an examination. The FDA work with companies to facilitate the voluntary recalls of products.

They occasionally inform the public about potentially dangerous products, which may motivate businesses to cooperate with the FDA in seeking a resolution.

In addition to placing a product on import alert or detaining it, if it seems hazardous or improperly labelled, the FDA now has the option of collaborating with the Department of Justice to take legal action.

The FDA further maintains a watch out for products distributed as cosmetics that falsely promise to change the body’s structure or function. Such claims are illegal for cosmetics to make.

How should one report an adverse event to the FDA?

FDA encourages consumer and medical professional reports of adverse events that are as detailed as possible, including the name and contact information of the individual who experienced the reaction as well as demographic data, such as age, gender, and ethnicity, to help identify whether any particular groups are disproportionately affected.

They also want details on any medical interventions, their results, and the product believed to be responsible for the adverse event, including its purchase location and intended usage.

Any identifying information about the product, such as the batch and lot numbers, is very crucial in order to find the manufacturer and, if required, to aid in a recall.

The FDA aims to increase the number of reports from health professionals and patients who have encountered an adverse event by making the Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS) database public.

Increased transparency will lead to more thorough reports, making it easier for the FDA to spot warning signs of potential safety issues with the products being regulated.

Anybody can file a complaint about the safety or quality of conventional food, cosmetics, or dietary supplements subject to FDA regulation.


Which substances are not allowed to be used in cosmetics?

Bithionol, mercury compounds, vinyl chloride, halogenated salicylanilides, zirconium complexes in aerosol cosmetics, chloroform, methylene chloride, chlorofluorocarbon propellants, and hexachlorophene are among the components that are restricted or outright banned by regulations.
Cosmetic and fragrance trade organisations have advised avoiding or restricting the use of a number of components linked to health hazards in addition to those that are governed by law or were the focus of a court decision.
Even if a cosmetic does not include an ingredient that is expressly forbidden or restricted by law, it is illegal to promote one that is hazardous to consumers when they use it as directed on the packaging or in the usual or anticipated manner.

What steps does the FDA take to prevent hazardous pollutants like lead from being present in cosmetic products?

The FDA keeps an eye out for possible safety issues, including hazardous pollutants, in cosmetics that are on the market. In order to be aware of potential issues, FDA also keep up with scientific studies. FDA pursue legal action against businesses and people who sell illegal goods as well as against the products themselves.
·         Examining Imports
Working with U.S. Customs and Border Protection personnel to monitor imported products is one method the FDA protects against tainted cosmetics. FDA issues Import Alerts to assist inspection employees in looking out for items that are most likely to pose a safety danger since we are unable to check every shipment. Several of our import alerts for cosmetics raise the possibility of hazardous contamination in certain products. Cosmetics that are deemed dangerous are prohibited from entering this nation.
·         Examining Manufacturers
In order to prevent the formation of two types of pollutants, nitrosamines and 1,4-dioxane, during the manufacturing process, the FDA has provided instructions to manufacturers. FDA inspectors ensure manufacturers are following the correct processes by conducting inspections.

Disclaimer: Regulations/legislations are subjected to changes from time to time and the author claims no responsibility for the accuracy of information.

Animal Testing for Cosmetics

Animal Testing for Cosmetics

The term “animal testing” refers to procedures carried out on living animals for research into basic biology and diseases, evaluating the efficacy of new pharmaceuticals, and testing the safety of consumer and industry products such as cosmetics, household cleaners, food additives, pharmaceuticals, and industrial/agrochemicals for human health and/or the environment.

Since 1937, people have used animals to test cosmetics and pharmaceuticals. To determine a product’s safety, manufacturers who want to sell new cosmetic products may utilise animal testing.

Companies may decide that animal testing is required in some situations to ensure the safety of a product or ingredient after carefully weighing potential alternatives.


The Food and Drug Administration (FDA), in charge of enforcing the Federal Food, Drug and Cosmetic Act, forbids the sale of mislabelled and “adulterated” cosmetics but does not demand safety tests on animals.

Animals are employed to evaluate the safety of cosmetic goods. The FDA encourages the development and use of alternatives to whole-animal testing as well as adherence to the most humane procedures feasible within the bounds of scientific competence.

The Animal Welfare Act and the Public Health Service Policy on Humane Care and Use of Laboratory Animals are two laws, along with other rules and policies that govern animal testing that FDA supports and abides.

Additionally, the FDA promotes using the least possible numbers of animals in research and testing while still using the most humane techniques feasible within the bounds of scientific capabilities. This is relevant in all situations when animal testing is employed. 

“Cruelty-Free” or “Not Tested on Animals” on cosmetic labelling

On their labels or advertising, several cosmetic firms claim that their products are “Cruelty-Free” or “Not Tested on Animals.” Because these terminologies don’t have any official definitions, cosmetic manufacturers are free to use them as they please.

Some companies could limit these claims to their final cosmetic products. To confirm the safety of their products or ingredients, these companies may rely on raw material suppliers or contracted laboratories.

Other cosmetic manufacturers may utilise a combination of scientific research, non-animal testing, testing for the safety of raw materials, and controlled human-use testing to support the safety of their products.


Previously, the Chinese government mandated that all cosmetics products undergo animal testing. Fortunately, some of these rules have been removed from Chinese cosmetics regulations.

In 2014, China encouraged companies that produced ‘common’ cosmetics (such mascara or shampoo) domestically to avoid using animals in testing, although imported goods were still subject to the requirement.

China revised its regulations in 2021 to allow some businesses to bring in common cosmetics without first subjecting them to animal testing. However, “special use” cosmetics like sunscreens and hair colour still need to be tested on animals, and many non-animal test techniques are still not authorised by Chinese authorities.


In the European Union, testing cosmetics on animals and marketing such products became prohibited in 2013. This paved the door for efforts to identify alternatives to the typical cosmetics tests that employ animals.

Similar laws have been enacted in Iceland, India, Israel, Mexico, Norway and Switzerland. Animal testing by cosmetic firms in the US and elsewhere prevents them from selling their goods in these nations until they modify their procedures. Legislation banning the sale of cosmetics that were tested on animals has been approved in California, Hawaii, Illinois, Maine, Maryland, Nevada, New Jersey, and Virginia. Several Brazilian states, as well as Australia, Colombia, Guatemala, New Zealand, South Korea, Taiwan, and Turkey, have established legislation that prohibits or restricts the use of animals in the testing of cosmetics.


Numerous products presently on the market are created using components with a lengthy history of safe usage and don’t call for extra testing. Businesses can guarantee safety by deciding to use such materials to manufacture products.

Additionally, companies can choose between utilising currently available non-animal testing or investing in and creating non-animal tests for novel substances.

There are already nearly 50 non-animal tests available, and many more are being developed. These contemporary alternatives can more nearly simulate how people react to cosmetic components and goods than animal experiments, and they are frequently quicker and less expensive.

In place of old animal tests that were established decades ago, advanced non-animal testing reflects the most current approaches that science has to offer.

Some businesses utilise animal testing to determine the safety of new compounds before developing or incorporating them into their cosmetic goods.

Some claim that this method is unnecessary and cruel because businesses can already create innovative products with hundreds of chemicals that have a track record of safety and don’t need any more testing.

Furthermore, alternative, quicker, less costly, and more trustworthy procedures have replaced antiquated animal experiments. These methods include computer models and human cell-based studies.

Disclaimer: Regulations/legislations are subjected to changes from time to time and the author claims no responsibility for the accuracy of information.